Phase II clinical trial of docetaxel in combination with gemcitabine in platinum-resistant ovarian cancer and primary peritoneal carcinoma.
Phase of Trial: Phase II
Latest Information Update: 30 Jan 2014
At a glance
- Drugs Docetaxel (Primary) ; Gemcitabine (Primary)
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 23 Jun 2009 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
- 23 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.